1
|
Kaiser AM, Forsthuber M, Aro R, Kärrman A, Gundacker C, Zeisler H, Foessleitner P, Salzer H, Hartmann C, Uhl M, Yeung LWY. Extractable Organofluorine Analysis in Pooled Human Serum and Placental Tissue Samples from an Austrian Subpopulation-A Mass Balance Analysis Approach. Environ Sci Technol 2021; 55:9033-9042. [PMID: 34133125 PMCID: PMC8277134 DOI: 10.1021/acs.est.1c00883] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Embryos and fetuses are of major concern due to their high vulnerability. Previous studies demonstrated that human exposure to per- and polyfluoroalkyl substances (PFAS) may be underestimated because only a limited number of known PFAS can be measured. This investigation studied the total PFAS exposure by measuring the extractable organofluorine (EOF) in pooled maternal serum, placental tissue, and cord serum samples (total number of pooled samples: n = 45). The EOF was analyzed using combustion ion chromatography, and the concentrations of known PFAS were determined using ultraperformance liquid chromatography coupled with a tandem mass spectrometer. Using a mass balance analysis approach, the amount of unknown PFAS was estimated between the levels of known PFAS and EOF. The EOF levels ranged from 2.85 to 7.17 ng F/mL (21 PFAS were quantified) in the maternal serum, from 1.02 to 1.85 ng F/g (23 PFAS were quantified) in the placental tissue, and from 1.2 to 2.10 ng F/mL (18 PFAS were quantified) in the cord serum. An average of 24, 51, and 9% of EOF is unidentified in the maternal serum, placental tissue, and cord serum, respectively. The results show that the levels of unidentified EOF are higher in the placental tissue, suggesting accumulation or potential transformation of precursors in the placenta.
Collapse
Affiliation(s)
- Andreas-Marius Kaiser
- Environment
Agency Austria, Spittelauer
Lände 5, A-1090 Vienna, Austria
- Institute
of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, A-1090 Vienna, Austria
| | - Martin Forsthuber
- Institute
of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, A-1090 Vienna, Austria
- Department
of Environmental Health, Center for Public Health, Medical University of Vienna, A-1090 Vienna, Austria
| | - Rudolf Aro
- Man-Technology-Environment
Research Centre (MTM), Örebro University, 701 82 Örebro, Sweden
| | - Anna Kärrman
- Man-Technology-Environment
Research Centre (MTM), Örebro University, 701 82 Örebro, Sweden
| | - Claudia Gundacker
- Institute
of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, A-1090 Vienna, Austria
| | - Harald Zeisler
- Department
of Obstetrics and Gynecology, Medical University
Vienna, A-1090 Vienna, Austria
| | - Philipp Foessleitner
- Department
of Gynecology and Obstetrics, University
Hospital St. Poelten, A-3100 St. Poelten, Austria
| | - Hans Salzer
- Clinic
for Pediatrics and Adolescent Medicine, University Hospital Tulln, A-3430 Tulln, Austria
| | | | - Maria Uhl
- Environment
Agency Austria, Spittelauer
Lände 5, A-1090 Vienna, Austria
| | - Leo W. Y. Yeung
- Man-Technology-Environment
Research Centre (MTM), Örebro University, 701 82 Örebro, Sweden
| |
Collapse
|